Hospira LifeCare PCA Infusion System
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LifeCare PCA Infusion System | unaffected |
|
Configuration 1 [-]
| AND |
|
No data.
No data available yet.
Vendor Solution
ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002.
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2014-5294 | The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459. |
No CVSS v4.0
No CVSS v3.1
No CVSS v3.0
This CVE is not in the KEV list.
Exploit prediction score: 1.2% (1.218% probability within 30 days)
Key SSVC decision points have not yet been added.
| Type | Values Removed | Values Added |
|---|---|---|
| Title | Hospira LifeCare PCA Infusion System | |
| References |
| |
| Metrics |
cvssV2_0
|
cvssV2_0
|